Serum OX40 levels may reflect the severity of disease in patients with oral squamous cell carcinoma and may aid in the rationalizing for investigating serum levels and prescribing anti-OX40 agonists in such patients in the future. Here, TNFRSF4 is linked to oral cavity squamous cell carcinoma.